Abstract
Psoriasis is a chronic inflammatory immune-mediated systemic disease. The therapeutic options depend on many factors.
In recent years, systemic treatment of psoriasis has made significant progress. In order to optimize and individualize the treatment, the guidelines have been developed.
Despite their regular updates, new scientific knowledge and up-to-date guidance should be followed.